Cephalalgia

Article	Citations
Efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block versus topiramate monotherapy for the preventive treatment of chronic migraine: A randomized controll	111
Genetic characterization of the endocannabinoid system and psychiatric features in patients with migraine and medication overuse headache	90
Evidence-based guidelines for the pharmacological treatment of migraine	88
A reply, drug-induced reversible cerebral vasoconstriction syndrome: Lessons from the real world	82
Harassment in the headache field: a global web-based cross-sectional survey	69
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials	66
International Classification of Headache Disorders-4 – Work in Progress 1	65
Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care	55
Population-based prevalence of cranial autonomic symptoms in migraine and proposed diagnostic appendix criteria	50
Call for papers	48
The effects of certain TRP channels and voltage-gated KCNQ/Kv7 channel opener retigabine on calcitonin gene-related peptide release in the trigeminovascular system	45
Pain sensitivities predict prophylactic treatment outcomes of flunarizine in chronic migraine patients: A prospective study	44
Effect of Altmetric score on manuscript citations: A randomized-controlled trial	40
Diagnosis of idiopathic intracranial hypertension - the importance of excluding secondary causes: A systematic review	40
An altered reward system characterizes chronic migraine with medication overuse headache	36
Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury	35
Systemic lupus erythematosus mimicking retinal migraine: a case report	35
Depression screening in migraine - A double-edged sword	34
Triptan non-response in a London tertiary headache centre: What can we learn? A retrospective study	32
Childhood and adolescent headache: A problem not to be ignored in the era of new therapies	32
Painful nervus intermedius neuropathy attributed to Bell's palsy: The need for independent diagnostic criteria	31
Corrigendum to: Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex	31
Comment on “What predicts citation counts and translational impact in headache research? A machine learning analysis”	31
Paroxysmal hemicrania and hemicrania continua: Review on pathophysiology, clinical features and treatment	30
Genome-wide DNA methylation analysis in an antimigraine-treated preclinical model of cortical spreading depolarization	30

Immunogenicity of erenumab: A pooled analysis of six placebo-controlled trials with long-term extensions	29
Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1st edition	29
History of maternal migraine and its association with preeclampsia: A case–control study in a low-resource setting in Sudan, Africa	29
COVID-19 vaccination-triggered cluster headache episodes with frequent attacks	29
Genome sequencing reveals the Adgrl3 ( ADGRL3 ) gene as a possible cause of cephalic hypersensitivity in the STA rat and migraine in human	28
Sensitivity of the SNNOOP10 list in the high-risk secondary headache detection	28
Real-world efficacy of galcanezumab for the treatment of migraine in Korean patients	28
Salivary CGRP can monitor the different migraine phases: CGRP (in)dependent attacks	27
Comorbidity or combination – more evidence for cluster-migraine?	27
Galcanezumab modulates Capsaicin-induced C-fiber reactivity	27
Looking at Cephalalgia from the inside	26
A placebo-controlled, randomized, single and multiple dose study to evaluate the safety, tolerability, and pharmacokinetics of rimegepant in healthy participants	26
Case reports: Could sexual dysfunction in women with migraine be a side effect of CGRP inhibition?	25
Effect of COVID vaccination on monthly migraine days: a longitudinal cohort study	25
Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: Updated analysis in VigiBase®	24
The midfacial segment pain: little known disorder in need of scientific evaluation	24
Long-term open-label and real-world studies of lasmiditan, ubrogepant, and rimegepant for the acute treatment of migraine attacks	24
Physical impairment during and between migraine attacks: A daily diary study of patients with chronic migraine	24
The non-decussating and decussating trigeminothalamic tracts in humans: A combination of connectome-based tractography and histological validation	24
What is the evolutionary disadvantage of migraine?	23
Author response to ‘Clarification on the incidence and sex-specificity of sexual dysfunction as an adverse event of CGRP-targeting medications’	23
Sex differences in photophobic behaviors following cortical spreading depression in rats	22
Crossing the Rubicon? The future impact of artificial intelligence on headache medicine	22
Migraine and risk of atrial fibrillation: A 9-year follow-up based on the Trøndelag Health Study	22
Abstracts from the International Headache Congress 14–17 September 2023	21
Thanks to Reviewers	21
Guidelines Update: Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine in children and adolescents, 1st edition – An experience-based update	21
Burden of headache in a HIV-positive population of sub-Saharan Africa	21
Psychophysical testing in chronic migraine and chronic tension type headache: An observational study	20
Muscae volitantes: A 19th-century precursor of visual snow syndrome?	19
Advancing understanding of migraine pathophysiology and therapy by consideration of patient sex	19
Alopecia as an emerging adverse event to CGRP monoclonal antibodies: Cases Series, evaluation of FAERS, and literature review	19
Involvement of adenosine signaling pathway in migraine pathophysiology: A systematic review of clinical studies	19
Worldwide availability of medications for migraine and tension-type headache: A survey of the International Headache Society	19
Migraine-attributed burden, impact and disability, and migraine-impacted quality of life: Expert consensus on definitions from a Delphi process	18
Efficacy of eptinezumab in non-responders to subcutaneous monoclonal antibodies against CGRP and the CGRP receptor: A retrospective cohort study	18
Corneal confocal microscopy identifies corneal nerve fiber loss in patients with migraine	18
Are we closer to achieving precision medicine for migraine treatment? A narrative review	18
The “index vein” as a sign for migraine aura in the emergency setting	18
Abnormal heart rate variability and its application in predicting treatment efficacy in patients with chronic migraine: An exploratory study	18
Effectiveness of anti-CGRP monoclonal antibodies and onabotulinumtoxinA in menstrually-related migraine: The unmet need of perimenstrual headache days	18
Internet and social media's role in migraine education: Headache or not headache?	17
Are the ICHD-3 criteria for headache attributed to idiopathic intracranial hypertension valid? Headache phenotyping and field-testing in newly diagnosed idiopathic intracranial hypertension	17
Erratum	17
Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent he	17
Efficacy and safety of monoclonal antibodies targeting CGRP in migraine prevention. GRADE tables elaborated by the ad hoc working group of the International Headache Society	17
The impact of eating disorders on idiopathic intracranial hypertension	17
Shared genetics and causal relationships between migraine and thyroid function traits	16
Stroke due to small-vessel disease and migraine: A case–control study of a young adult with ischemic stroke population	16
Comorbidity with fibromyalgia predicted poorer outcomes in patients with chronic migraine on flunarizine: Prospective proof-of-concept study	16

Premonitory symptoms in migraine: A REFORM Study	16
Neurological and psychiatric comorbidities of migraine: Concepts and future perspectives	16
Exploring the association between familial hemiplegic migraine genes (CACNA1A, ATP1A2 and SCN1A) with migraine and epilepsy: A UK Biobank exome-wide association study	16
Corrigendum: No structural brain alterations in new daily persistent headache – a cross sectional VBM/SBM study	15
Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache	15
Board Walk – April 2022	15
Bridging the gaps of headache care for underserved populations: Current status of the headache field in Latin America	15
Avoidance behaviour modulates but does not condition phonophobia in migraine	15
Letter to the Editor regarding “Effect of Altmetric score on manuscript citations: A randomized-controlled trial”	15
Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients	15
Longitudinal trajectories of posttraumatic headache after pediatric mild traumatic brain injury	15
“Wearing-off” efficacy of CGRP monoclonal antibodies for migraine prevention: A meta-analysis of randomized controlled trials	15
BoNT-A efficacy in high frequency migraine: an open label, single arm, exploratory study applying the PREEMPT paradigm	15
Headache at the chronic stage of cerebral venous thrombosis	15
Hypnic Headache – What do we know in 2022?	15
Switching anti-CGRP(R) monoclonal antibodies in multi-assessed non-responder patients and implications for ineffectiveness criteria: A retrospective cohort study	14
Comment on “Lack of reproducibility of resting-state functional MRI findings in migraine with aura”	14
Proposed general diagnostic criteria for secondary headaches	14
Prevalence and treatment of typical and atypical headaches in patients with Chiari I malformation: A meta-analysis and literature review	14
Comparison of continuous headache features in youth with migraine, new daily persistent headache, and persistent post-traumatic headache	14
The long-term effect of work schedule, shift work disorder, insomnia and restless legs syndrome on headache among nurses: A prospective longitudinal cohort study	14
Children under 6 years with acute headache in Pediatric Emergency Departments. A 2-year retrospective exploratory multicenter Italian study	14
New migraine drugs: A critical appraisal of the reason why the majority of migraine patients do not receive an adequate medication	14
Reply to “Methodological considerations in assessing the impact of CGRP monoclonal antibodies on blood pressure”	13
Cigarette smoking history (personal and secondary childhood exposure) in non-cluster headache trigeminal autonomic cephalalgias: A clinic based study	13
Mutation screening and association analysis of NOTCH3 p.R544C in patients with migraine with or without aura	13
Recurrent Painful Ophthalmoplegic Neuropathy: A case report with atypical features and a review of the literature	13
Prevalence of neck pain in migraine: A systematic review and meta-analysis	13
Activation of the trigeminal system as a likely target of SARS-CoV-2 may contribute to anosmia in COVID-19	13
Electrophysiological findings in migraine may reflect abnormal synaptic plasticity mechanisms: A narrative review	13
What do people want to know about “Growing Up with Migraine”? Results of a preference survey of people with lived experience to guide future research	13
Erenumab versus topiramate for the prevention of migraine – a randomised, double-blind, active-controlled phase 4 trial	13
Orofacial pain for clinicians: A review of constant and attack-like facial pain syndromes	12
Cephalalgia: a legacy of excellence, a vision for tomorrow	12
Timing of headache after COVID-19 vaccines and its association with cerebrovascular events: An analysis of 41,700 VAERS reports	12
Late Breaking Author Index	12
Open-label trials for CGRP-targeted drugs in migraine prevention: A narrative review	12
Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies	12
Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with erenumab	12
Other primary headaches: Distinct clinical features and uncertain pathophysiology	12
Smooth muscle ATP-sensitive potassium channels mediate migraine-relevant hypersensitivity in mouse models	12
Longitudinal differences in iron deposition in periaqueductal gray matter and anterior cingulate cortex are associated with response to erenumab in migraine	12
A need for an expert consensus guideline on performing peripheral nerve blocks in headache patients	11
Migraine and the risk of stroke in a middle-aged and elderly population: A prospective cohort study	11
Treatment experiences and clinical characteristics in migraine and tension-type headache patients before the first visit to a tertiary headache center	11
Personal view: Modelling pain mechanisms of migraine without aura	11
Measuring headache day severity using multiple features in daily diary designs	11
How migraine and its associated treatment impact on pregnancy outcomes: Umbrella review with updated systematic review and meta-analysis	11
Comment on ‘'Correlation between endometriosis and migraine features: Results from a prospective case-control study'‘	11
Epicranial headaches part 2: Nummular headache and epicrania fugax	11
An evolving machine-learning-based algorithm to early predict response to anti-CGRP monoclonal antibodies in patients with migraine	11
Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort study	11
Persistent headache attributed to past cervicocephalic artery dissection: clinical characteristics and contributors to headache persistence	11
Recovery and long-term outcome after neurosurgical closure of spinal CSF leaks in patients with spontaneous intracranial hypotension	11
Multidisciplinary headache treatment with work-focus in Norway: An observational study	11
Headache provocation by nitric oxide in men who have never experienced a headache	11
Developing an artificial intelligence-based headache diagnostic model and its utility for non-specialists’ diagnostic accuracy	11
Oxygen inhalation has no effect on provoked cranial autonomic symptoms using kinetic oscillation stimulation in healthy volunteers	11
Primary headache disorders in adolescents in North- and South-Tyrol: Findings of the EVA-Tyrol-Study	10
Open label experience of repeated OnabotulinumtoxinA injections towards the sphenopalatine ganglion in patients with chronic cluster headache and chronic migraine	10
Health care resource utilization and costs associated with diagnosed medication overuse headache and potential acute medication overuse in individuals with migraine	10
Lack of a direct link between macular cones function and photophobia in interictal migraine	10
Overuse of analgesics can affect the fertility biomarker Anti-Müllerian Hormone in females. A translational study	10
Pathophysiology of cluster headache: From the trigeminovascular system to the cerebral networks	10
Migraine and risk of hypertensive disorders of pregnancy: A population-based cohort study	10
Non-invasive vagus nerve stimulation for prevention of migraine: The multicenter, randomized, double-blind, sham-controlled PREMIUM II trial	10
Migraine and insufficient sleep: The effect of sleep restriction on nociceptive evoked potentials in migraine	10
Update in the understanding of new daily persistent headache	10
The SIH-EBP Score: A grading scale to predict the response to the first epidural blood patch in spontaneous intracranial hypotension	10
NCOR2 is a novel candidate gene for migraine-epilepsy phenotype	9
It is a long way to the top if you wanna citations?	9
The evolutionary meaning of migraine	9
The chicken and egg problem: CGRP release due to trigeminal activation or vice versa?	9
FollowTheSutures: Piloting a new way to administer onabotulinumtoxinA for chronic migraine	9
ANODYNE study: A double-blind randomized trial of greater occipital nerve block of methylprednisolone and lignocaine versus placebo as a transitional preventive treatment for episodic cluster headache	9
Phenotyping non-idiopathic pseudotumor cerebri syndrome – A prospective cohort study	9
The characteristics of COVID-19 vaccine-related headache: Clues gathered from the healthcare personnel in the pandemic	9
Visual snow syndrome is probably not mediated by CGRP: A case series	9
Functional magnetic resonance imaging in migraine: A systematic review	9
Investigations of the subarachnoid space as a potential link between aura and headache in migraine: A case-control MRI study	9

Characteristics of pre-cluster symptoms in cluster headache: A cross-sectional multicentre study	9
Effectiveness of physiotherapy interventions on headache intensity, frequency, duration and quality of life of patients with tension-type headache. A systematic review and network meta-analysis	9
Investigations of the migraine-provoking effect of levcromakalim in patients with migraine with aura	9
The influence of endogenous and exogenous hormonal factors on migraine in spontaneous postmenopausal women: A nationwide population-based study in South Korea	9
Transition of cluster headache phenotype: An interview-based study	9
Update on cough, exertional and sex headache	9
Bioequivalence of rimegepant, a small molecule CGRP receptor antagonist, administered as an oral tablet, a sublingual orally disintegrating tablet, and a supralingual orally disintegrating tablet: two	9
Aura in trigeminal autonomic cephalalgia is probably mediated by comorbid migraine with aura	9
Identification of patients with chronic migraine by using sensory-evoked oscillations from the electroencephalogram classifier	9
A narrative review of app- and internet-delivered headache interventions: From ideation to implementation and the future	9
Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine	9
A systematic evaluation of primary headache management apps leveraging behavior change techniques	9
Clinical analysis of 30 cases of cardiac cephalalgia	8
Sensitizing effect of antimigraine drug sumatriptan on capsaicin-sensitive lung vagal neurons via 5-HT 1B/1D receptors and PKA: Relevance to adverse chest effects	8
Diagnosis, knowledge, perception, and productivity impact of headache education and clinical evaluation program in the workplace at an information technology company of more than 70,000 employees	8
Studying migraine as a risk factor for stroke: The importance of working with an explicit causal framework	8
Comment on: Setting higher standards for migraine prevention: A position statement of the International Headache Society	8
Preventive CGRP-targeted therapies for chronic migraine with and without medication-overuse headache	8
Calcitonin receptor antibody validation and expression in the rodent brain	8
No structural brain alterations in new daily persistent headache – a cross sectional VBM/SBM study	8
Minimal important difference of the Migraine Disability Assessment (MIDAS): Longitudinal data from the DMKG Headache Registry	8
The prevalence of headache disorders in Postural Tachycardia Syndrome: A systematic review and meta-analysis of the literature	8
Epidemiology and clinical features of short-lasting unilateral neuralgiform headache attacks: A systematic review and meta-analysis	8
The monoclonal CGRP-receptor blocking antibody erenumab has different effects on brainstem and cortical sensory-evoked responses	8
Physical inactivity and headache disorders: Cross-sectional analysis in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)	8
Prolonged headache with vaccine- and dose-specific headache pattern associated with vaccine against SARS-CoV-2 in patients with migraine	8
Corrigendum to: “CLOCK gene circannual expression in cluster headache”	8
Pharmacologic characterization of atogepant: A potent and selective calcitonin gene–related peptide receptor antagonist	8
Enhanced audiovisual associative pair learning in migraine without aura in adult patients: An unexpected finding	8
Prevalence, clinical characteristics and associated factors of cardiac cephalalgia: A prospective study	8
Effect of KATP channel blocker glibenclamide on PACAP38-induced headache and hemodynamic	8
What proportion of people with migraine report postdromal symptoms? A systematic review and meta-analysis of observational studies	8
Diagnosis of idiopathic intracranial hypertension: A proposal for evidence-based diagnostic criteria	8
Identification of brain areas in mice with peak neural activity across the acute and persistent phases of post-traumatic headache	8
Pharmacological modulation of ventral tegmental area neurons elicits changes in trigeminovascular sensory processing and is accompanied by glycemic changes: Implications for migraine	8
A randomized open-label study to evaluate the effectiveness and safety of once-daily rimegepant 75 mg orally disintegrating tablet for the short-term preventive treatment of fasting-triggered headache	8
Functional brainstem representations of the human trigeminal cervical complex	8
Thanks to Reviewers	7
Author Index	7
A response: Update on cough, exertional and sex headache	7
Indirect costs attributed to headache: A nation-wide survey of an active working population	7
Placebo and nocebo in the treatment of migraine: How much does real world effectiveness depend on contextual effects?	7
20th Congress of the International Headache Society September 8-12, 2021	7
Medication “underuse” headache	7
A comparative study on prophylactic efficacy of cinnarizine and amitriptyline in childhood migraine: a randomized double-blind clinical trial	7
Inhibiting PAC1 receptor internalization and endosomal ERK pathway activation may ameliorate hyperalgesia in a chronic migraine rat model	7
CLOCK gene circannual expression in cluster headache	7
The time sequence of brain MRI findings in spontaneous intracranial hypotension	7
Methodology of drug trials in migraine: History and suggestions for the future	7
Continuous positive airway pressure in cluster headache: A randomized, placebo-controlled, triple-blind, crossover study	7
Are PROMs passing the message? A reflection with real-life migraine patients	7
The epidemiology of airplane headache: A cross-sectional study on point prevalence and characteristics in 50,000 travelers	7
The effect of blood pressure lowering medications on the prevention of episodic migraine: A systematic review and meta-analysis	7
Genome-wide association study reveals susceptibility loci for self-reported headache in a large community-based Asian population	7
Raising the bar in migraine prevention: Toward freedom and optimal control	7
DNA-methylation and immunological response in medication overuse headache	6
Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data	6
Headache characteristics and postoperative course in Chiari I malformation	6
Effects of substance P on headache induction and arterial dilation in healthy adults	6
What do patients’ efficacy and tolerability ratings of acute migraine medication tell us? Cross-sectional data from the DMKG Headache Registry	6
Response to letter to the editor: “What predicts citation counts and translational impact in headache research? A machine learning analysis”	6
IHS Regional Headache Conference abstracts: 2022	6
COVID-19 vaccination elicited de novo and recurrence of cluster headache: A case series	6
Pediatric screen exposure and school related headache disability	6
New migraine drugs	6
Interim analysis of the Registry for Load and Management of Medication Overuse Headache (RELEASE): A multicenter, comprehensive medication overuse headache registry	6
Longitudinal analysis of pain-induced brain activations in post-traumatic headache	6
Identification and characterization of migraine in pregnancy: A Norwegian registry-based cohort study	6
Promoting excellence in scientific peer review: The Cephalalgia Reviewer Academy	6
Effectiveness of transcranial direct current stimulation and monoclonal antibodies acting on the CGRP as a combined treatment for migraine (TACTIC): Results of a randomized controlled trial	6
High-frequency repetitive transcranial magnetic stimulation at dorsolateral prefrontal cortex for migraine prevention: A systematic review and meta-analysis	6
An analysis of diffusion tensor imaging in classical trigeminal neuralgia	6
Clarification on the incidence and sex-specificity of sexual dysfunction as an adverse event of CGRP-targeting medications	6
Time to retire ‘New daily persistent headache’: Mode of onset of chronic migraine and tension-type headache	6
The role of cytokines in migraine: A systematic review	6
A male-specific mechanism of meningeal nociceptor sensitization promoting migraine headache	6
Building community and visibility: A year of social media growth for Cephalalgia	6
Sex differences in effectiveness of CGRP receptor antagonism for treatment of acute and persistent headache-like pain in a mouse model of mild traumatic brain injury	6
Perceived barriers to career progression in the headache field: A global web-based cross-sectional survey	6
A national Swedish case-control study investigating incidence and factors associated with idiopathic intracranial hypertension	6
PACAP38- and VIP-induced cluster headache attacks are not associated with changes of plasma CGRP or markers of mast cell activation	6
IHC 2021 Late breaking abstracts	6
Breaking barriers in migraine care: Advancing gender medicine to bridge the gap for men	5
Anti-calcitonin gene-related peptide monoclonal antibodies for the treatment of vestibular migraine: A prospective observational cohort study	5
Induction of cGMP-mediated migraine attacks is independent of CGRP receptor activation	5
Thanks to Reviewers	5
Treatment pattern and response for cluster headache in Korea: A prospective multicenter observation study	5
Chronic cluster headache: A study of the telencephalic and cerebellar cortical thickness	5
Disability in migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study	5
Peripherally acting anti-CGRP monoclonal antibodies attenuate cortical resting-state connectivity in migraine patients	5
Guidelines of the International Headache Society for Real-World Evidence studies in migraine and cluster headache	5
REPLY to Comment on Correlation between endometriosis and migraine features: Results from a prospective case-control study'': Correlation between endometriosis and migraine features is not based on a	5
Update on “Treatment of orthostatic headache without intracranial hypotension: A case report” – nine years later	5
Reply to “What is the evolutionary disadvantage of migraine?”	5
Effects of acupuncture and medical training therapy on depression, anxiety, and quality of life in patients with frequent tension-type headache: A randomized controlled study	5